| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 36 | 2023 | 263 | 6.400 |
Why?
|
| Sleep, REM | 50 | 2019 | 93 | 5.010 |
Why?
|
| Neurons | 41 | 2019 | 881 | 4.580 |
Why?
|
| Neuropeptides | 20 | 2013 | 106 | 4.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2013 | 216 | 3.670 |
Why?
|
| Wakefulness | 23 | 2021 | 75 | 2.830 |
Why?
|
| Hypothalamus | 12 | 2019 | 78 | 2.680 |
Why?
|
| Narcolepsy | 10 | 2017 | 45 | 2.380 |
Why?
|
| Cataplexy | 5 | 2017 | 25 | 2.300 |
Why?
|
| Pons | 18 | 2013 | 35 | 2.250 |
Why?
|
| Hypothalamic Hormones | 4 | 2019 | 13 | 2.210 |
Why?
|
| Pituitary Hormones | 4 | 2019 | 16 | 2.210 |
Why?
|
| Melanins | 4 | 2019 | 24 | 2.200 |
Why?
|
| Orexins | 17 | 2017 | 52 | 1.840 |
Why?
|
| Zona Incerta | 2 | 2023 | 4 | 1.710 |
Why?
|
| Proto-Oncogene Proteins c-fos | 20 | 2008 | 114 | 1.420 |
Why?
|
| Animals | 86 | 2023 | 20877 | 1.300 |
Why?
|
| Circadian Rhythm | 15 | 2013 | 218 | 1.180 |
Why?
|
| Plant Proteins | 6 | 2007 | 48 | 1.150 |
Why?
|
| Rats | 50 | 2016 | 5300 | 1.140 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 9 | 2009 | 21 | 1.130 |
Why?
|
| Adenosine | 4 | 2008 | 165 | 1.050 |
Why?
|
| Prosencephalon | 5 | 2008 | 38 | 1.030 |
Why?
|
| Electroencephalography | 27 | 2013 | 418 | 1.000 |
Why?
|
| Toxins, Biological | 7 | 2009 | 23 | 0.940 |
Why?
|
| Rats, Sprague-Dawley | 30 | 2008 | 2083 | 0.910 |
Why?
|
| Periodicity | 3 | 2008 | 43 | 0.880 |
Why?
|
| Optogenetics | 3 | 2017 | 20 | 0.840 |
Why?
|
| Sleep Deprivation | 11 | 2014 | 81 | 0.830 |
Why?
|
| Action Potentials | 3 | 2016 | 223 | 0.810 |
Why?
|
| Hypothalamic Area, Lateral | 3 | 2008 | 17 | 0.810 |
Why?
|
| Aging | 6 | 2007 | 911 | 0.790 |
Why?
|
| Mice | 21 | 2023 | 8472 | 0.780 |
Why?
|
| Choline O-Acetyltransferase | 9 | 2006 | 30 | 0.740 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2006 | 91 | 0.710 |
Why?
|
| Nerve Tissue Proteins | 7 | 2007 | 290 | 0.710 |
Why?
|
| Carrier Proteins | 4 | 2004 | 597 | 0.700 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 79 | 0.660 |
Why?
|
| Immunohistochemistry | 18 | 2013 | 1174 | 0.660 |
Why?
|
| Immunotoxins | 4 | 2006 | 23 | 0.650 |
Why?
|
| Electromyography | 15 | 2013 | 184 | 0.620 |
Why?
|
| Hypothalamus, Posterior | 2 | 2015 | 6 | 0.620 |
Why?
|
| Arousal | 5 | 2008 | 168 | 0.610 |
Why?
|
| Neurosciences | 1 | 2017 | 15 | 0.600 |
Why?
|
| Periaqueductal Gray | 2 | 2023 | 9 | 0.590 |
Why?
|
| Receptors, Neuropeptide | 4 | 2004 | 22 | 0.570 |
Why?
|
| N-Glycosyl Hydrolases | 3 | 2006 | 9 | 0.560 |
Why?
|
| Brain | 9 | 2017 | 2175 | 0.550 |
Why?
|
| Amygdala | 2 | 2016 | 159 | 0.540 |
Why?
|
| Genetic Therapy | 3 | 2016 | 291 | 0.530 |
Why?
|
| Reticular Formation | 8 | 2004 | 13 | 0.510 |
Why?
|
| Male | 47 | 2021 | 37281 | 0.510 |
Why?
|
| Gene Transfer Techniques | 3 | 2013 | 173 | 0.510 |
Why?
|
| Homeostasis | 2 | 2006 | 291 | 0.470 |
Why?
|
| Genes, fos | 4 | 2000 | 22 | 0.470 |
Why?
|
| Cholinergic Fibers | 6 | 1998 | 27 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 9 | 2016 | 2790 | 0.460 |
Why?
|
| Astrocytes | 1 | 2015 | 270 | 0.450 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2023 | 208 | 0.410 |
Why?
|
| Mice, Knockout | 8 | 2014 | 1692 | 0.410 |
Why?
|
| Subthalamus | 1 | 2011 | 3 | 0.400 |
Why?
|
| Nerve Degeneration | 3 | 2007 | 134 | 0.400 |
Why?
|
| Body Temperature | 8 | 2005 | 116 | 0.390 |
Why?
|
| Acetylcholine | 6 | 1998 | 64 | 0.380 |
Why?
|
| Motor Activity | 6 | 2008 | 621 | 0.380 |
Why?
|
| Receptors, Muscarinic | 7 | 1998 | 44 | 0.380 |
Why?
|
| Locus Coeruleus | 4 | 2002 | 55 | 0.370 |
Why?
|
| Carbachol | 6 | 1996 | 34 | 0.360 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2006 | 18 | 0.350 |
Why?
|
| Delta Rhythm | 4 | 2016 | 11 | 0.350 |
Why?
|
| Preoptic Area | 8 | 2008 | 19 | 0.330 |
Why?
|
| Caloric Restriction | 1 | 2008 | 22 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2550 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 2 | 2006 | 510 | 0.290 |
Why?
|
| Temperature | 1 | 2008 | 340 | 0.290 |
Why?
|
| Nuclear Proteins | 2 | 2007 | 271 | 0.280 |
Why?
|
| Muscle Tonus | 2 | 2004 | 9 | 0.270 |
Why?
|
| Physical Conditioning, Animal | 1 | 2005 | 34 | 0.270 |
Why?
|
| Caffeine | 1 | 2006 | 81 | 0.270 |
Why?
|
| Gene Expression | 4 | 2001 | 770 | 0.270 |
Why?
|
| Arachidonic Acids | 2 | 2014 | 97 | 0.270 |
Why?
|
| Cats | 13 | 1996 | 292 | 0.260 |
Why?
|
| Electrodes, Implanted | 6 | 2013 | 98 | 0.260 |
Why?
|
| Substantia Nigra | 1 | 2005 | 102 | 0.260 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2003 | 28 | 0.260 |
Why?
|
| Histamine | 1 | 2004 | 52 | 0.250 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2003 | 16 | 0.240 |
Why?
|
| Brain Chemistry | 2 | 2004 | 173 | 0.240 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 221 | 0.230 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2005 | 71 | 0.230 |
Why?
|
| Transcription Factor AP-1 | 2 | 2001 | 61 | 0.230 |
Why?
|
| Orexin Receptors | 4 | 2004 | 11 | 0.230 |
Why?
|
| Brain Injuries | 1 | 2006 | 268 | 0.230 |
Why?
|
| Lipopolysaccharides | 2 | 2004 | 455 | 0.220 |
Why?
|
| GABAergic Neurons | 1 | 2023 | 17 | 0.220 |
Why?
|
| Receptors, Cholinergic | 6 | 1994 | 30 | 0.220 |
Why?
|
| RNA, Messenger | 8 | 2008 | 1663 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2006 | 1745 | 0.210 |
Why?
|
| Norepinephrine | 2 | 2004 | 276 | 0.210 |
Why?
|
| Brain Mapping | 4 | 2019 | 531 | 0.210 |
Why?
|
| Parasympathetic Nervous System | 2 | 1992 | 14 | 0.210 |
Why?
|
| Sleep Wake Disorders | 1 | 2003 | 94 | 0.200 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2021 | 2 | 0.200 |
Why?
|
| Neural Pathways | 7 | 2008 | 323 | 0.200 |
Why?
|
| Genotype | 3 | 2011 | 785 | 0.200 |
Why?
|
| Activity Cycles | 2 | 2016 | 5 | 0.200 |
Why?
|
| Microdialysis | 3 | 2008 | 147 | 0.200 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2004 | 167 | 0.200 |
Why?
|
| Female | 9 | 2021 | 38015 | 0.190 |
Why?
|
| Dioxolanes | 2 | 1991 | 8 | 0.190 |
Why?
|
| Atropine | 2 | 1991 | 29 | 0.190 |
Why?
|
| Rats, Long-Evans | 2 | 2016 | 203 | 0.190 |
Why?
|
| Parasympathomimetics | 4 | 1993 | 13 | 0.180 |
Why?
|
| Cell Count | 5 | 2004 | 248 | 0.180 |
Why?
|
| Endocannabinoids | 2 | 2014 | 32 | 0.180 |
Why?
|
| Rats, Inbred F344 | 3 | 2005 | 104 | 0.180 |
Why?
|
| Optical Imaging | 1 | 2019 | 46 | 0.170 |
Why?
|
| Rats, Inbred Strains | 5 | 1998 | 532 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2000 | 189 | 0.170 |
Why?
|
| Symporters | 1 | 1998 | 27 | 0.160 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 415 | 0.160 |
Why?
|
| Inflammation | 1 | 2004 | 1030 | 0.160 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2673 | 0.150 |
Why?
|
| Supraoptic Nucleus | 3 | 2003 | 5 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 282 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 41 | 0.150 |
Why?
|
| Neuroglia | 1 | 2017 | 136 | 0.140 |
Why?
|
| Models, Biological | 3 | 1998 | 981 | 0.140 |
Why?
|
| In Situ Hybridization | 4 | 2008 | 201 | 0.140 |
Why?
|
| Medulla Oblongata | 3 | 1991 | 19 | 0.140 |
Why?
|
| Microinjections | 5 | 2001 | 130 | 0.140 |
Why?
|
| Reaction Time | 4 | 2006 | 170 | 0.130 |
Why?
|
| Injections, Intraventricular | 2 | 2005 | 50 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 929 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1995 | 39 | 0.130 |
Why?
|
| Mammals | 1 | 1995 | 47 | 0.130 |
Why?
|
| Sodium Chloride | 1 | 1995 | 136 | 0.130 |
Why?
|
| Gallamine Triethiodide | 2 | 1991 | 2 | 0.120 |
Why?
|
| Pirenzepine | 2 | 1991 | 17 | 0.120 |
Why?
|
| Emotions | 1 | 2016 | 244 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2008 | 191 | 0.120 |
Why?
|
| Channelrhodopsins | 1 | 2013 | 7 | 0.120 |
Why?
|
| Adenosine Deaminase | 2 | 2004 | 6 | 0.120 |
Why?
|
| Color | 1 | 2013 | 50 | 0.120 |
Why?
|
| Muscarinic Antagonists | 2 | 1993 | 54 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 1032 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 381 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 204 | 0.110 |
Why?
|
| Biperiden | 2 | 1993 | 2 | 0.110 |
Why?
|
| Photic Stimulation | 1 | 2013 | 229 | 0.110 |
Why?
|
| Time Factors | 7 | 2004 | 4655 | 0.110 |
Why?
|
| Plasmids | 1 | 2013 | 258 | 0.110 |
Why?
|
| Humans | 13 | 2017 | 68525 | 0.110 |
Why?
|
| Cricetinae | 3 | 2008 | 262 | 0.100 |
Why?
|
| Thalamic Nuclei | 1 | 1990 | 9 | 0.100 |
Why?
|
| Oxotremorine | 2 | 1989 | 6 | 0.100 |
Why?
|
| Raphe Nuclei | 3 | 2002 | 10 | 0.100 |
Why?
|
| Electrooculography | 2 | 2006 | 5 | 0.100 |
Why?
|
| Depressive Disorder | 2 | 1992 | 621 | 0.090 |
Why?
|
| (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride | 1 | 1989 | 1 | 0.090 |
Why?
|
| Neurotransmitter Agents | 3 | 2008 | 102 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1989 | 20 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 710 | 0.090 |
Why?
|
| Injections | 2 | 2003 | 119 | 0.090 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2014 | 17 | 0.090 |
Why?
|
| Gyrus Cinguli | 2 | 2001 | 113 | 0.080 |
Why?
|
| Isoflurophate | 1 | 1988 | 9 | 0.080 |
Why?
|
| Receptors, Opioid | 1 | 2008 | 60 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 200 | 0.080 |
Why?
|
| Fasting | 1 | 2008 | 75 | 0.080 |
Why?
|
| Ataxin-3 | 1 | 2007 | 4 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2008 | 311 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 63 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2001 | 470 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2001 | 954 | 0.080 |
Why?
|
| Nicotine | 1 | 1990 | 350 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 376 | 0.070 |
Why?
|
| Peptides | 2 | 2007 | 455 | 0.070 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2006 | 3 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2007 | 682 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2007 | 182 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 614 | 0.070 |
Why?
|
| Brain Tissue Transplantation | 1 | 2004 | 10 | 0.070 |
Why?
|
| Ventral Tegmental Area | 1 | 2005 | 74 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 257 | 0.060 |
Why?
|
| Ibotenic Acid | 2 | 2001 | 9 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 65 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 164 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2014 | 2688 | 0.060 |
Why?
|
| Period Circadian Proteins | 1 | 2004 | 16 | 0.060 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 35 | 0.060 |
Why?
|
| Occipital Lobe | 1 | 2003 | 18 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 32 | 0.060 |
Why?
|
| Cerebellum | 1 | 2004 | 103 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1039 | 0.060 |
Why?
|
| Walking | 1 | 2006 | 240 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2004 | 396 | 0.060 |
Why?
|
| Polysomnography | 1 | 2004 | 92 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 1293 | 0.060 |
Why?
|
| Species Specificity | 2 | 1997 | 302 | 0.060 |
Why?
|
| Sincalide | 1 | 2003 | 12 | 0.060 |
Why?
|
| Secretin | 1 | 2003 | 18 | 0.060 |
Why?
|
| Alleles | 1 | 2004 | 386 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2003 | 30 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2003 | 156 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 230 | 0.050 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2001 | 6 | 0.050 |
Why?
|
| Hypothalamus, Anterior | 1 | 2001 | 2 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 901 | 0.050 |
Why?
|
| Trigeminal Nuclei | 1 | 2001 | 2 | 0.050 |
Why?
|
| Cochlear Nucleus | 1 | 2001 | 2 | 0.050 |
Why?
|
| Genes, Immediate-Early | 1 | 2001 | 13 | 0.050 |
Why?
|
| Memory | 2 | 1980 | 214 | 0.050 |
Why?
|
| Phenotype | 1 | 2004 | 946 | 0.050 |
Why?
|
| Body Weight | 1 | 2003 | 554 | 0.050 |
Why?
|
| Video Recording | 1 | 2001 | 145 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2001 | 489 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1851 | 0.050 |
Why?
|
| Sleep Stages | 1 | 2000 | 30 | 0.050 |
Why?
|
| Suprachiasmatic Nucleus | 2 | 2001 | 7 | 0.050 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2 | 1990 | 3 | 0.050 |
Why?
|
| Wheat Germ Agglutinins | 2 | 1990 | 5 | 0.050 |
Why?
|
| Horseradish Peroxidase | 2 | 1990 | 27 | 0.050 |
Why?
|
| Electrophysiology | 3 | 2008 | 160 | 0.050 |
Why?
|
| Oxytocin | 2 | 1992 | 124 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2004 | 753 | 0.040 |
Why?
|
| Blood Pressure | 1 | 1986 | 1447 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 782 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 532 | 0.040 |
Why?
|
| Mutation | 1 | 2004 | 1213 | 0.040 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 1998 | 21 | 0.040 |
Why?
|
| Receptor, Muscarinic M5 | 1 | 1998 | 1 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 1998 | 10 | 0.040 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 1998 | 8 | 0.040 |
Why?
|
| Lac Operon | 1 | 1997 | 54 | 0.040 |
Why?
|
| Transgenes | 1 | 1997 | 92 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 88 | 0.040 |
Why?
|
| Saline Solution, Hypertonic | 2 | 1995 | 21 | 0.040 |
Why?
|
| Cell Line | 1 | 2001 | 1752 | 0.040 |
Why?
|
| Learning | 1 | 1979 | 186 | 0.040 |
Why?
|
| Brain Stem | 2 | 1988 | 46 | 0.040 |
Why?
|
| Retina | 1 | 1999 | 252 | 0.040 |
Why?
|
| Reference Values | 2 | 1995 | 579 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2008 | 7028 | 0.040 |
Why?
|
| Mammillary Bodies | 1 | 1996 | 1 | 0.040 |
Why?
|
| Biomarkers | 2 | 2000 | 1593 | 0.030 |
Why?
|
| Secretory Rate | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cholinergic Agents | 1 | 1995 | 12 | 0.030 |
Why?
|
| Kinetics | 2 | 1995 | 1047 | 0.030 |
Why?
|
| Mollusca | 1 | 1995 | 14 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 189 | 0.030 |
Why?
|
| Vasopressins | 1 | 1995 | 33 | 0.030 |
Why?
|
| Darkness | 2 | 2002 | 27 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1995 | 282 | 0.030 |
Why?
|
| Glycerides | 1 | 2014 | 18 | 0.030 |
Why?
|
| Benzoxazines | 1 | 2014 | 20 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 25 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 17 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 41 | 0.030 |
Why?
|
| Neocortex | 1 | 2014 | 17 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2014 | 47 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 79 | 0.030 |
Why?
|
| Light | 2 | 2002 | 152 | 0.030 |
Why?
|
| Histocytochemistry | 2 | 1999 | 149 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2014 | 68 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 562 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 235 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2014 | 190 | 0.030 |
Why?
|
| Adult | 2 | 2006 | 21375 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1995 | 1199 | 0.030 |
Why?
|
| Catalepsy | 1 | 1991 | 8 | 0.030 |
Why?
|
| Synapses | 1 | 2014 | 222 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1991 | 31 | 0.030 |
Why?
|
| Galanin | 2 | 2002 | 3 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2001 | 32 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1990 | 37 | 0.020 |
Why?
|
| Microspheres | 1 | 1990 | 59 | 0.020 |
Why?
|
| Cortical Synchronization | 1 | 1990 | 6 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 261 | 0.020 |
Why?
|
| Cholera Toxin | 2 | 2002 | 30 | 0.020 |
Why?
|
| Stress, Physiological | 2 | 1990 | 215 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2008 | 32 | 0.020 |
Why?
|
| Dynorphins | 1 | 2008 | 69 | 0.020 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2008 | 37 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2008 | 35 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1990 | 411 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 2008 | 70 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 639 | 0.020 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2001 | 15 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2008 | 152 | 0.020 |
Why?
|
| Interneurons | 1 | 2008 | 70 | 0.020 |
Why?
|
| Affective Disorders, Psychotic | 1 | 1987 | 23 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 184 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 236 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 1986 | 39 | 0.020 |
Why?
|
| Amitriptyline | 1 | 1986 | 11 | 0.020 |
Why?
|
| Infant | 1 | 1991 | 2891 | 0.020 |
Why?
|
| Area Postrema | 1 | 2003 | 2 | 0.010 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2003 | 5 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2003 | 19 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 498 | 0.010 |
Why?
|
| Septal Nuclei | 1 | 2003 | 31 | 0.010 |
Why?
|
| Photoperiod | 1 | 2002 | 11 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2003 | 238 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 334 | 0.010 |
Why?
|
| Avoidance Learning | 2 | 1980 | 58 | 0.010 |
Why?
|
| Denervation | 1 | 2000 | 23 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2000 | 29 | 0.010 |
Why?
|
| Anisomycin | 1 | 1980 | 1 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2000 | 59 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1980 | 45 | 0.010 |
Why?
|
| Proactive Inhibition | 1 | 1979 | 1 | 0.010 |
Why?
|
| Electroshock | 1 | 1979 | 36 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1999 | 31 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1999 | 77 | 0.010 |
Why?
|
| Drinking | 1 | 1994 | 35 | 0.010 |
Why?
|
| Trihexyphenidyl | 1 | 1993 | 1 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1993 | 19 | 0.010 |
Why?
|
| Hippocampus | 2 | 1986 | 471 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1992 | 17 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1993 | 41 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1993 | 206 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 167 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1990 | 282 | 0.010 |
Why?
|
| Dogs | 1 | 1991 | 490 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1990 | 195 | 0.010 |
Why?
|
| Cranial Nerves | 1 | 1988 | 3 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1988 | 196 | 0.000 |
Why?
|
| Caudate Nucleus | 1 | 1986 | 56 | 0.000 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1986 | 10 | 0.000 |
Why?
|
| Tremor | 1 | 1986 | 16 | 0.000 |
Why?
|
| Depression | 1 | 1993 | 942 | 0.000 |
Why?
|
| Smoking | 1 | 1993 | 1449 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1986 | 435 | 0.000 |
Why?
|